# Statistics and Interpretation of Evidence

(there are 33 questions in this topic)

Question 24 |

Question 28 |

Question 11 |
Definitions of terms in statistics: prevalence, relative risk and attributable risk |

Question 20 |

Question 19 |

Question 8 |

Question 13 |
Meta-analysis: advantages and disadvantages. Also, the funnel plot |

Question 26 |

Question 5 |
Meta-analysis: advantages and disadvantages. Also, publication bias. |

Question 8 |
Analysis of clinical trials: overall assessment of quality |

Question 17 |

Question 23 |
Definitions: Risk ratio, NNT, P-value and confidence interval. |

Question 29 |

Question 9 |
Definitions Relative risk, absolute risk, NNT, and the power of a study. |

Question 19.1 |
Calculate sensitivity, specificity, PPV and NPV |

Question 19.2 |
Calculate: Relative risk, absolute risk, NNT |

Question 24 |

Question 10 |
Meta-analysis: the forest plot. Its anatomy in some detail. |

Question 23 |
Definitions: Type 1 error, type 2 error, study power, sample size and effect size. |

Question 29.1 |
Definitions: Phase III trial, absolute and relative risk reduction, NNT. |

Question 29.2 |
Calculate sensitivity, specificity, PPV and NPV. |

Question 30 |
Meta-analysis: features suggestive of "high quality". |

Question 15 |
Definitions: sensitivity, specificity, PPV NPV and the positive likelihood ratio. |

Question 10 |
Define intention to treat analysis and randomisation. |

Question 25 |
Definitions: relative risk, absolute risk, NNT and study power. |

Question 21 |

Question 13 |
Definitions: sensitivity, specificity, PPV and NPV. |

Question 4 |

Question 6 |
Analysis of clinical trials: Methodological quality |

Question 4 |
Tests of statistical significance: Chi-squared test, Fisher’s Exact Test and logistic regression. |

Question 14 |
Definitions: sensitivity, specificity, PPV and NPV. |

Question 2b | |

Question 2c |
Analysis of clinical trials: criteria used to assess validity. |